Loading the section…

PRVA: financial statements from SEC — TradeAlmanac

PRVA

Privia Health Group, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	604M	580M	521M	480M	438M	422M
Selling, general and administrative	41M	40M	38M	32M	31M	29M
Operating expenses	596M	566M	518M	475M	432M	417M
Operating income	7M	14M	3M	5M	6M	5M
Pre-tax income	9M	17M	6M	8M	8M	8M
Income tax	6M	7M	2M	2M	4M	3M
Net income	3M	7M	3M	6M	4M	5M
Earnings per share	0.02	0.06	0.02	0.03	0.03	0.03
Earnings per share, diluted	0.02	0.05	0.02	0.03	0.03	0.03
Weighted average shares	124M	123M	122M	121M	120M	119M
Weighted average shares, diluted	131M	129M	128M	128M	126M	125M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	420M	480M	441M	390M	469M	491M	422M	387M
Receivables	514M	401M	499M

Cash flow

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Operating cash flow	−49M	—	—	−24M	—	—
Depreciation and amortisation	3M	3M	3M	2M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator